Top Markets
Coin of the day
In Veritas Medical Diagnostics, Inc. In Veritas Medical Diagnostics, Inc.

In Veritas Medical Diagnostics, Inc.

IVME
株式のランク #41113
In Veritas Medical Diagnostics, Inc. (IVME) is a company currently in its... In Veritas Medical Diagnostics, Inc. (IVME) is a company currently in its development phase, dedicated to researching and creating advanced medical devices for point-of-care diagnostics. Their leading product is a prothrombin monitor, which assesses blood coagulation in patients at risk of cardiovascular diseases and strokes. The company is also actively developing an array of other diagnostic tools. These include a consumer-oriented device to predict the onset of labor for maternity planning, a comprehensive biomarker monitor capable of identifying indicators for conditions such as heart attacks, HIV, cholesterol levels, and cancer. Further innovations under development feature a non-invasive device for continuous blood glucose concentration measurement, a digital scanning machine designed as a non-invasive alternative to traditional 2D X-rays, and an osteoporosis device providing instant bone mineral density readings for patients. Additionally, they are working on a portable digital strip reader for immunoassay applications. Formerly known as In Vivo Medical Diagnostics, Inc., the company officially adopted its current name in 2005. Its operations are headquartered in Inverness, United Kingdom.
株価
$0.0007
最終同期: 2025-09-02
時価総額
$42.26K
変化(1日)
0.00%
変化(1年)
0.00%
GB
取引 In Veritas Medical Diagnostics, Inc. (IVME)

カテゴリー

In Veritas Medical Diagnostics, Inc.(IVME)の配当利回りの履歴
In Veritas Medical Diagnostics, Inc.(銘柄コード: IVME)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
In Veritas Medical Diagnostics, Inc.(IVME)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)